Home  >  Products  >  C21ORF33 Blocking Peptide (100ug)
C21ORF33 Blocking Peptide (100ug)

C21ORF33 Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-C21orf33 antibody (Catalogue #: ARP45817_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP45817
Size: 100 ug
Weight: 21kDa
Gene: 8209
Format: Lyophilized powder
Target: C21orf33 inhibits both estrogen- and heregulin-beta1-stimulated growth of breast cancer cells, and further suggests that growth inhibition induced in these cells by all-trans retinoic acid occurs via HES-1-mediated downregulation of E2F-1 expression. C21orf33 may also be a candidate protein involved in the pathogenesis of the brain deficit in DS.
Alternative names: D21S2048E; ES1; GT335; HES1; KNP-I; KNPH; KNPI
See Full Product Listings >